Fluvoxamine-induced reversible euprolactinemic galactorrhea in a case of obsessive-compulsive disorder

Fluvoxamine is one of the commonly used selective serotonin reuptake inhibitors (SSRIs) as a first-line treatment for obsessive-compulsive disorder (OCD). Galactorrhea is a rarely observed adverse effect of SSRIs occurring through complex interactions between serotonergic and dopaminergic systems of...

Full description

Saved in:
Bibliographic Details
Published inAnnals of Indian Psychiatry Vol. 1; no. 2; pp. 127 - 128
Main Authors Vispute, ChetanDilip, Parkar, ShubhangiR, Singh, DeepikaA
Format Journal Article
LanguageEnglish
Published Wolters Kluwer Medknow Publications 01.01.2017
Subjects
Fluvoxamine
galactorrhea
serotonin reuptake inhibitor
Online AccessGet full text

Cover

More Information
Summary:Fluvoxamine is one of the commonly used selective serotonin reuptake inhibitors (SSRIs) as a first-line treatment for obsessive-compulsive disorder (OCD). Galactorrhea is a rarely observed adverse effect of SSRIs occurring through complex interactions between serotonergic and dopaminergic systems of brain. We report a case of fluvoxamine-induced reversible euprolactinemic galactorrhea in a 39-year-old woman after initiation of fluvoxamine for OCD. The patient's galactorrhea resolved on discontinuation of fluvoxamine.
ISSN:2588-8358
2588-8366
DOI:10.4103/aip.aip_18_17